Hear one of our university partners discuss new research with the PAXgene® Blood ccfDNA System:

Dr. Michael Fleischhacker – University Medical Center Halle/Saale 
A standardized approach for the quantification of cell-free methylated plasma DNA in lung cancer patients

Postponed to: Wednesday, September 22, 2:00 pm,  Session: Regulation & Quality Insurance

We will also be featuring two scientific posters demonstrating new workflow benefits and performance effectiveness of the PAXgene Blood ccfDNA System:

1. A shortened, automated workflow for processing plasma directly from primary blood collection tubes reduces turnaround time and risk of sample mix-up in ccfDNA based applications.

2. Performance Evaluation of Collection/Stabilization/Purification Systems for Liquid Biopsy Cancer Biomarker Applications